Results 271 to 280 of about 655,937 (417)

Circulating tumor cells in metastatic breast cancer patients treated with immune checkpoint inhibitors – a biomarker analysis of the ALICE and ICON trials

Molecular Oncology, EarlyView.
In this explorative biomarker analysis, we assessed serial sampling of circulating tumor cells (CTCs) with CellSearch in two randomized trials testing immune checkpoint inhibitors (ICIs) in metastatic breast cancer. Our data demonstrate a prognostic potential of CTCs, most apparent 4 weeks into ICI therapy.
Nikolai Kragøe Andresen, Andreas Hagen Røssevold, Elin Borgen, Cecilie Bendigtsen Schirmer, Bjørnar Gilje, Øystein Garred, Jon Lømo, Marius Stensland, Oddmund Nordgård, Ragnhild Sørum Falk, Randi R. Mathiesen, Hege G. Russnes, Jon Amund Kyte, Bjørn Naume   +13 more
wiley   +1 more source

Examining kidney donation in Nigeria: a mixed methods study of family members' knowledge, perceptions, information needs and decision-making. [PDF]

BMC Nephrol
Mamven M, Adejumo OA, Edeki IR, Oyedepo DS, Ngoka SC, Abdu A, Tuko MT, Adeyeye LA, Loskurima U, Fasaanu A, Madu NC, Angbazo D, Ummate I.   +12 more
europepmc   +1 more source

Oocyte donation: Problems with oocyte donation [PDF]

Human Reproduction, 1996
openaire   +2 more sources

Circulating tumor cells: advancing personalized therapy in small cell lung cancer patients

Molecular Oncology, EarlyView.
Small cell lung cancer (SCLC) is an aggressive form of lung cancer that spreads rapidly to secondary sites such as the brain and liver. Cancer cells circulating in the blood, “circulating tumor cells” (CTCs), have demonstrated prognostic value in SCLC, and evaluating biomarkers on CTCs could guide treatment decisions such as for PARP inhibitors ...
Prajwol Shrestha, Steven Kao, Veronica K. Cheung, Wendy A. Cooper, Nico van Zandwijk, John E. J. Rasko, Dannel Yeo   +6 more
wiley   +1 more source

Serum uric acid level is associated with renal arteriolar hyalinosis and predicts post-donation renal function in living kidney donors. [PDF]

PLoS One
Kano Y, Tanabe K, Kitagawa M, Sugiyama H, Yamanoi T, Yoshinaga K, Bekku K, Nishimura S, Araki M, Wada J.   +9 more
europepmc   +1 more source

Kidney donation after circulatory death (DCD): state of the art.

Kidney International, 2015
D. Summers, D. Summers, C. Watson, G. Pettigrew, Rachel J. Johnson, D. Collett, J. Neuberger, J. Bradley   +7 more
semanticscholar   +1 more source

A comparative study of circulating tumor cell isolation and enumeration technologies in lung cancer

Molecular Oncology, EarlyView.
Lung cancer cells were spiked into donor blood to evaluate the recovery rates of the following circulating tumor cell (CTC) enrichment technologies: CellMag™, EasySep™, RosetteSep™, Parsortix® PR1, and Parsortix® Prototype systems. Each method's advantages and disadvantages are described.
Volga M Saini, Ezgi Oner, Mark P. Ward, Sinead Hurley, Brian David Henderson, Faye Lewis, Stephen P. Finn, Gerard J. Fitzmaurice, John J. O'Leary, Sharon O'Toole, Lorraine O'Driscoll, Kathy Gately   +11 more
wiley   +1 more source

Cell‐free and extracellular vesicle microRNAs with clinical utility for solid tumors

Molecular Oncology, EarlyView.
Cell‐free microRNAs (cfmiRs) are small‐RNA circulating molecules detectable in almost all body biofluids. Innovative technologies have improved the application of cfmiRs to oncology, with a focus on clinical needs for different solid tumors, but with emphasis on diagnosis, prognosis, cancer recurrence, as well as treatment monitoring.
Yoshinori Hayashi, Janelle‐Cheri Millen, Romela Irene Ramos, Jennifer A. Linehan, Timothy G. Wilson, Dave S. B. Hoon, Matias A. Bustos   +6 more
wiley   +1 more source

Organ donation [PDF]

, 1989
J. Collin
openalex   +1 more source

Attitudes towards living organ donation: a cross-sectional survey study. [PDF]

Front Public Health
Naibauer S, Branagan WT, Lehto S, Reynolds N, Mikulich-Gilbertson S, Page CE, Davis RA.   +6 more
europepmc   +1 more source